세계의 자궁근종 색전술 기기 시장 보고서(2025년)

Uterine Fibroid Embolization Device Global Market Report 2025

US $ 4,490 ￦ 6,242,000

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 6,490 ￦ 9,023,000

PDF (Site License)

PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 8,490 ￦ 11,803,000

PDF (Enterprise License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

자궁근종 색전술 기기 시장 규모는 향후 몇 년 동안 안정적인 성장세를 보이며 2029년까지 연평균 4.4%의 CAGR로 70억 4,000만 달러에 달할 것으로 예상됩니다. 예측 기간 동안의 성장은 비침습적 치료에 대한 인식의 증가, 헬스케어 서비스의 세계 확대, 여성 건강 관리 개념의 증가, 다학제적 치료와의 통합, 외래 환자 서비스 확대 등에 기인하는 것으로 보입니다. 예측 기간의 주요 동향으로는 최소침습적 치료법 채택 증가, 색전술의 발전, 개별화된 치료 접근법, 외래 UFE 치료에 대한 집중, 영상 기술의 통합, 생체흡수성 색전술에 대한 연구 등이 있습니다.

최소침습 수술에 대한 수요 증가는 자궁근종 색전술 기기 시장의 성장을 견인할 것으로 예상됩니다. 최소침습 수술은 작은 절개나 자연 개구부를 통해 환자의 신체에 최소한의 외상을 입히면서 내부 장기, 조직, 구조물에 접근하여 치료하는 수술입니다. 자궁근종 색전술은 침습을 최소화하면서 자궁근종을 효과적으로 치료할 수 있어 이러한 시술에서 중요한 역할을 하고 있습니다. 이러한 특수 기기는 작은 절개창을 사용하도록 설계되어 주변 조직에 미치는 영향을 줄이고, 덜 침습적인 의료에 대한 선호도가 높아짐에 따라 궁극적으로 환자의 예후를 개선할 수 있습니다. 예를 들어, 2023년 8월 미국 성형외과 및 미용 의료 단체인 The Aesthetic Society는 미국인들이 미용 성형에 지출한 금액이 118억 달러를 넘어 전년 대비 2% 증가했다고 보고했습니다. 이처럼 최소침습 수술에 대한 수요 증가가 자궁근종 색전술 기기 시장 확대를 견인하고 있습니다.

또한, 고령화의 진전은 자궁근종 색전술 기기 시장 확대에 기여할 것으로 예상되며, 65세 이상의 고령화 사회에서 자궁근종 색전술은 수술의 대안으로 최소침습적 치료법으로 주목받고 있습니다. 이 계층은 이러한 기기를 통해 과다출혈이나 골반통과 같은 증상 완화를 경험하고 있습니다. 세계보건기구(WHO)의 2022년 10월 보고서에 따르면, 60세 이상 세계 인구는 2022년 14억 명에 달하고 2050년에는 21억 명으로 두 배로 늘어날 것으로 예측됩니다. 따라서 고령화 인구의 증가는 자궁근종 색전술 기기 시장의 촉진요인이 되고 있습니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 - 금리, 인플레이션, 지정학, 코로나, 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

• 세계 자궁근종 색전술 기기 PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인, 억제요인)
• 최종 이용 산업 분석
• 세계의 자궁근종 색전술 기기 시장 : 성장률 분석
• 세계의 자궁근종 색전술 기기 시장 실적 : 규모와 성장, 2019-2024
• 세계의 자궁근종 색전술 기기 시장 예측 : 규모와 성장, 2024-2029, 2034F
• 세계 자궁근종 색전술 기기 전체 시장(TAM)

제6장 시장 세분화

• 세계의 자궁근종 색전술 기기 시장 : 기술별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
• 외과수술 기술
• 복강경 기술
• 절제 기술
• 색전술
• 세계의 자궁근종 색전술 기기 시장 : 치료 방법별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
• 침습적 치료
• 최소침습 치료
• 비침습적 치료
• 세계의 자궁근종 색전술 기기 시장 : 최종사용자별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
• 병원
• 클리닉
• 외래 수술 센터
• 세계의 자궁근종 색전술 기기 시장, 수술법 세분화, 종류별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
• 개복 수술
• 자궁근종절제술
• 세계의 자궁근종 색전술 기기 시장 복강경 수술 종류별 세분화, 실적과 예측, 2019-2024, 2024-2029F, 2034F
• 복강경 자궁근종절제술
• 복강경 자궁적출술
• 세계의 자궁근종 색전술 기기 시장, 절제 기술 하위 세분화, 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
• 고주파 절제
• 마이크로파 절제
• 냉동요법
• 세계의 자궁근종 색전술 기기 시장, 색전술 종류별 세분화, 실적과 예측, 2019-2024, 2024-2029F, 2034F
• 경카테터 동맥 색전술(TAE)
• 자궁 동맥 색전술(UAE)

제7장 지역별·국가별 분석

• 세계의 자궁근종 색전술 기기 시장 : 지역별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
• 세계의 자궁근종 색전술 기기 시장 : 국가별, 실적과 예측, 2019-2024, 2024-2029F, 2034F

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 개요

• 자궁근종 색전술 기기 시장 : 경쟁 구도
• 자궁근종 색전술 기기 시장 : 기업 개요
  • Johnson and Johnson Pvt Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • Medtronic plc. Overview, Products and Services, Strategy and Financial Analysis
  • Siemens Healthineers Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • Koninklijke Philips N.V. Overview, Products and Services, Strategy and Financial Analysis

제31장 기타 주요 기업과 혁신적 기업

• Stryker Corporation
• Boston Scientific Corporation
• GE HealthCare Technologies Inc.
• Olympus Corporation
• Terumo Corporation
• Smith and Nephew plc.
• Ethicon Inc.
• Hologic Inc.
• CooperSurgical Inc.
• Ferring B.V.
• Cook Medical Inc.
• Karl Storz GmbH
• Merit Medical Systems
• CONMED Corporation
• Amsino International Inc.

제32장 세계의 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병

제34장 최근의 시장 동향

제35장 시장 잠재력이 높은 국가, 부문, 전략

• 자궁근종 색전술 기기 시장 2029 : 새로운 기회를 제공하는 국가
• 자궁근종 색전술 기기 시장 2029 : 새로운 기회를 제공하는 부문
• 자궁근종 색전술 기기 시장 2029 : 성장 전략
  • 시장 동향에 기반한 전략
  • 경쟁 전략

제36장 부록

ksm

영문 목차

영문목차

A uterine fibroid embolization device is a medical device used in the treatment of noncancerous tumors, specifically uterine fibroids, through a minimally invasive procedure. Uterine fibroids are benign growths in the uterus, and this device functions by restricting the blood supply to these fibroids, causing them to shrink and ultimately disappear.

The main types of technologies associated with uterine fibroid embolization devices include surgical techniques, laparoscopic techniques, ablation techniques, and embolization techniques. Surgical techniques involve specific methods and procedures employed by medical professionals. These devices are utilized in various treatment modes, including invasive, minimally invasive, and non-invasive treatments. Additionally, they find application in diverse healthcare settings such as hospitals, clinics, and ambulatory surgical centers.

The uterine fibroid embolization device market research report is one of a series of new reports from The Business Research Company that provides uterine fibroid embolization device market statistics, including uterine fibroid embolization device industry global market size, regional shares, competitors with a uterine fibroid embolization device market share, detailed uterine fibroid embolization device market segments, market trends and opportunities, and any further data you may need to thrive in the uterine fibroid embolization device industry. This uterine fibroid embolization device market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The uterine fibroid embolization devices market size has grown strongly in recent years. It will grow from $5.62 billion in 2024 to $5.93 billion in 2025 at a compound annual growth rate (CAGR) of 5.6%. The growth in the historic period can be attributed to increasing incidence of uterine fibroids, preference for non-surgical alternatives, awareness and education initiatives, focus on women's health, shift towards outpatient procedures, physician training programs.

The uterine fibroid embolization devices market size is expected to see steady growth in the next few years. It will grow to $7.04 billion in 2029 at a compound annual growth rate (CAGR) of 4.4%. The growth in the forecast period can be attributed to increasing awareness of non-invasive treatments, global expansion of healthcare services, rise in female healthcare initiatives, integration with multidisciplinary care, expansion of outpatient services. Major trends in the forecast period include increasing adoption of minimally invasive procedures, advancements in embolic agents, personalized treatment approaches, focus on outpatient ufe procedures, integration of imaging technologies, research on bioresorbable embolic agents.

The increasing demand for minimally invasive surgeries is expected to drive the growth of the uterine fibroid embolization device market. Minimally invasive surgeries involve using small incisions or natural body openings to access and treat internal organs, tissues, or structures, minimizing trauma to the patient's body. Uterine fibroid embolization devices play a crucial role in these procedures by effectively treating uterine fibroids while keeping invasiveness to a minimum. These specialized devices are designed to use small incisions, reducing the impact on surrounding tissues, and catering to the rising preference for less invasive medical treatments, ultimately improving patient outcomes. For example, in August 2023, The Aesthetic Society, a US-based organization in plastic surgery and cosmetic medicine, reported that Americans spent over $11.8 billion on aesthetic procedures, marking a 2% increase from the previous year. Thus, the growing demand for minimally invasive surgeries is driving the expansion of the uterine fibroid embolization device market.

The growing aging population is also expected to contribute to the expansion of the uterine fibroid embolization devices market. The aging population, representing individuals aged 65 years and older, benefits from uterine fibroid embolization devices as a minimally invasive alternative to surgery for addressing symptomatic fibroids. This demographic experiences relief from symptoms such as excessive bleeding and pelvic pain through these devices. According to the World Health Organization's October 2022 report, the global population aged 60 years and older reached 1.4 billion in 2022, and by 2050, it is projected to double to 2.1 billion. Therefore, the increasing aging population acts as a driver for the uterine fibroid embolization devices market.

Major companies in the uterine fibroid embolization device market are focusing on developing innovative products such as the TruClear system to address the growing demand for minimally invasive treatments for uterine fibroids, aiming to enhance safety and efficacy. The TruClear system, launched by Medtronic Private Limited in November 2022, is a mechanical hysteroscopic tissue removal system used for treating intrauterine abnormalities. It features a flexible catheter inserted through the cervix into the uterus, incorporating a spinning nitinol wire loop, continuous inflow and outflow, integrated suction, and high-definition imaging, contributing to the precision and safety of uterine fibroid treatment.

In October 2024, Hologic Inc., a US-based medical technology company, acquired Gynesonics for $350 million. Through this acquisition, Hologic seeks to expand its range of minimally invasive treatment options for women's health, with a focus on managing uterine fibroids and heavy menstrual bleeding. Gynesonics Inc. is a US-based medical technology company specializing in the development of minimally invasive solutions for treating symptomatic uterine fibroids.

Major companies operating in the uterine fibroid embolization device market report are Johnson and Johnson Pvt Ltd., Abbott Laboratories, Medtronic plc., Siemens Healthineers Ltd., Koninklijke Philips N.V., Stryker Corporation, Boston Scientific Corporation, GE HealthCare Technologies Inc., Olympus Corporation, Terumo Corporation, Smith and Nephew plc., Ethicon Inc., Hologic Inc., CooperSurgical Inc., Ferring B.V., Cook Medical Inc., Karl Storz GmbH, Merit Medical Systems, CONMED Corporation, Amsino International Inc., Lumenis Ltd., Richard Wolf GmbH, BTG International Ltd., Healthium MedTech Pvt. Ltd., INSIGHTEC Ltd., Hironic Co.Ltd., Minerva Surgical Inc., Gynesonics Inc., Advanced Surgical Concepts PLLC, Hitachi Medical Corporation

North America was the largest region in the uterine fibroid embolization device market in 2024. The regions covered in the uterine fibroid embolization device market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the uterine fibroid embolization device market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The uterine fibroid embolization device market consists of revenues earned by entities by provide services such as minimally invasive procedures, non-invasive procedures, minimally invasive procedures, radiofrequency ablation, medication and hormonal therapy, and embolization procedures. The market value includes the value of related goods sold by the service provider or included within the service offering. The uterine fibroid embolization device market also includes sales of medications, hysteroscopic devices, laparoscopic devices, radiofrequency ablation devices, endometrial ablation devices, hysterectomy devices, and robotic surgical systems. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Uterine Fibroid Embolization Device Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on uterine fibroid embolization device market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for uterine fibroid embolization device ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The uterine fibroid embolization device market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Technology: Surgical Techniques; Laparoscopic Techniques; Ablation Techniques; Embolization Techniques
• 2) By Mode Of Treatment: Invasive Treatment; Minimally Invasive Treatment; Non-Invasive Treatment
• 3) By End User: Hospitals; Clinics; Ambulatory Surgical Center
• Subsegments:
• 1) By Surgical Techniques: Open Surgery; Myomectomy
• 2) By Laparoscopic Techniques: Laparoscopic Myomectomy; Laparoscopic Hysterectomy
• 3) By Ablation Techniques: Radiofrequency Ablation; Microwave Ablation; Cryoablation
• 4) By Embolization Techniques: Transcatheter Arterial Embolization (TAE); Uterine Artery Embolization (UAE)
• Companies Mentioned: Johnson and Johnson Pvt Ltd.; Abbott Laboratories; Medtronic plc.; Siemens Healthineers Ltd.; Koninklijke Philips N.V.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Uterine Fibroid Embolization Device Market Characteristics

3. Uterine Fibroid Embolization Device Market Trends And Strategies

4. Uterine Fibroid Embolization Device Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Uterine Fibroid Embolization Device Growth Analysis And Strategic Analysis Framework

• 5.1. Global Uterine Fibroid Embolization Device PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Uterine Fibroid Embolization Device Market Growth Rate Analysis
• 5.4. Global Uterine Fibroid Embolization Device Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Uterine Fibroid Embolization Device Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Uterine Fibroid Embolization Device Total Addressable Market (TAM)

6. Uterine Fibroid Embolization Device Market Segmentation

• 6.1. Global Uterine Fibroid Embolization Device Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Surgical Techniques
• Laparoscopic Techniques
• Ablation Techniques
• Embolization Techniques
• 6.2. Global Uterine Fibroid Embolization Device Market, Segmentation By Mode Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Invasive Treatment
• Minimally Invasive Treatment
• Non-Invasive Treatment
• 6.3. Global Uterine Fibroid Embolization Device Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Clinics
• Ambulatory Surgical Center
• 6.4. Global Uterine Fibroid Embolization Device Market, Sub-Segmentation Of Surgical Techniques, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Open Surgery
• Myomectomy
• 6.5. Global Uterine Fibroid Embolization Device Market, Sub-Segmentation Of Laparoscopic Techniques, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Laparoscopic Myomectomy
• Laparoscopic Hysterectomy
• 6.6. Global Uterine Fibroid Embolization Device Market, Sub-Segmentation Of Ablation Techniques, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Radiofrequency Ablation
• Microwave Ablation
• Cryoablation
• 6.7. Global Uterine Fibroid Embolization Device Market, Sub-Segmentation Of Embolization Techniques, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Transcatheter Arterial Embolization (TAE)
• Uterine Artery Embolization (UAE)

7. Uterine Fibroid Embolization Device Market Regional And Country Analysis

• 7.1. Global Uterine Fibroid Embolization Device Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Uterine Fibroid Embolization Device Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Uterine Fibroid Embolization Device Market

• 8.1. Asia-Pacific Uterine Fibroid Embolization Device Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Uterine Fibroid Embolization Device Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Uterine Fibroid Embolization Device Market, Segmentation By Mode Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Uterine Fibroid Embolization Device Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Uterine Fibroid Embolization Device Market

• 9.1. China Uterine Fibroid Embolization Device Market Overview
• 9.2. China Uterine Fibroid Embolization Device Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Uterine Fibroid Embolization Device Market, Segmentation By Mode Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Uterine Fibroid Embolization Device Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Uterine Fibroid Embolization Device Market

• 10.1. India Uterine Fibroid Embolization Device Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Uterine Fibroid Embolization Device Market, Segmentation By Mode Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Uterine Fibroid Embolization Device Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Uterine Fibroid Embolization Device Market

• 11.1. Japan Uterine Fibroid Embolization Device Market Overview
• 11.2. Japan Uterine Fibroid Embolization Device Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Uterine Fibroid Embolization Device Market, Segmentation By Mode Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Uterine Fibroid Embolization Device Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Uterine Fibroid Embolization Device Market

• 12.1. Australia Uterine Fibroid Embolization Device Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Uterine Fibroid Embolization Device Market, Segmentation By Mode Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Uterine Fibroid Embolization Device Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Uterine Fibroid Embolization Device Market

• 13.1. Indonesia Uterine Fibroid Embolization Device Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Uterine Fibroid Embolization Device Market, Segmentation By Mode Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Uterine Fibroid Embolization Device Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Uterine Fibroid Embolization Device Market

• 14.1. South Korea Uterine Fibroid Embolization Device Market Overview
• 14.2. South Korea Uterine Fibroid Embolization Device Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Uterine Fibroid Embolization Device Market, Segmentation By Mode Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Uterine Fibroid Embolization Device Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Uterine Fibroid Embolization Device Market

• 15.1. Western Europe Uterine Fibroid Embolization Device Market Overview
• 15.2. Western Europe Uterine Fibroid Embolization Device Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Uterine Fibroid Embolization Device Market, Segmentation By Mode Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Uterine Fibroid Embolization Device Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Uterine Fibroid Embolization Device Market

• 16.1. UK Uterine Fibroid Embolization Device Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Uterine Fibroid Embolization Device Market, Segmentation By Mode Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Uterine Fibroid Embolization Device Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Uterine Fibroid Embolization Device Market

• 17.1. Germany Uterine Fibroid Embolization Device Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Uterine Fibroid Embolization Device Market, Segmentation By Mode Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Uterine Fibroid Embolization Device Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Uterine Fibroid Embolization Device Market

• 18.1. France Uterine Fibroid Embolization Device Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Uterine Fibroid Embolization Device Market, Segmentation By Mode Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Uterine Fibroid Embolization Device Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Uterine Fibroid Embolization Device Market

• 19.1. Italy Uterine Fibroid Embolization Device Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Uterine Fibroid Embolization Device Market, Segmentation By Mode Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Uterine Fibroid Embolization Device Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Uterine Fibroid Embolization Device Market

• 20.1. Spain Uterine Fibroid Embolization Device Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Uterine Fibroid Embolization Device Market, Segmentation By Mode Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Uterine Fibroid Embolization Device Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Uterine Fibroid Embolization Device Market

• 21.1. Eastern Europe Uterine Fibroid Embolization Device Market Overview
• 21.2. Eastern Europe Uterine Fibroid Embolization Device Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Uterine Fibroid Embolization Device Market, Segmentation By Mode Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Uterine Fibroid Embolization Device Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Uterine Fibroid Embolization Device Market

• 22.1. Russia Uterine Fibroid Embolization Device Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Uterine Fibroid Embolization Device Market, Segmentation By Mode Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Uterine Fibroid Embolization Device Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Uterine Fibroid Embolization Device Market

• 23.1. North America Uterine Fibroid Embolization Device Market Overview
• 23.2. North America Uterine Fibroid Embolization Device Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Uterine Fibroid Embolization Device Market, Segmentation By Mode Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Uterine Fibroid Embolization Device Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Uterine Fibroid Embolization Device Market

• 24.1. USA Uterine Fibroid Embolization Device Market Overview
• 24.2. USA Uterine Fibroid Embolization Device Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Uterine Fibroid Embolization Device Market, Segmentation By Mode Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Uterine Fibroid Embolization Device Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Uterine Fibroid Embolization Device Market

• 25.1. Canada Uterine Fibroid Embolization Device Market Overview
• 25.2. Canada Uterine Fibroid Embolization Device Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Uterine Fibroid Embolization Device Market, Segmentation By Mode Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Uterine Fibroid Embolization Device Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Uterine Fibroid Embolization Device Market

• 26.1. South America Uterine Fibroid Embolization Device Market Overview
• 26.2. South America Uterine Fibroid Embolization Device Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Uterine Fibroid Embolization Device Market, Segmentation By Mode Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Uterine Fibroid Embolization Device Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Uterine Fibroid Embolization Device Market

• 27.1. Brazil Uterine Fibroid Embolization Device Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Uterine Fibroid Embolization Device Market, Segmentation By Mode Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Uterine Fibroid Embolization Device Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Uterine Fibroid Embolization Device Market

• 28.1. Middle East Uterine Fibroid Embolization Device Market Overview
• 28.2. Middle East Uterine Fibroid Embolization Device Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Uterine Fibroid Embolization Device Market, Segmentation By Mode Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Uterine Fibroid Embolization Device Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Uterine Fibroid Embolization Device Market

• 29.1. Africa Uterine Fibroid Embolization Device Market Overview
• 29.2. Africa Uterine Fibroid Embolization Device Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Uterine Fibroid Embolization Device Market, Segmentation By Mode Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Uterine Fibroid Embolization Device Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Uterine Fibroid Embolization Device Market Competitive Landscape And Company Profiles

• 30.1. Uterine Fibroid Embolization Device Market Competitive Landscape
• 30.2. Uterine Fibroid Embolization Device Market Company Profiles
  • 30.2.1. Johnson and Johnson Pvt Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Medtronic plc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Siemens Healthineers Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Koninklijke Philips N.V. Overview, Products and Services, Strategy and Financial Analysis

31. Uterine Fibroid Embolization Device Market Other Major And Innovative Companies

• 31.1. Stryker Corporation
• 31.2. Boston Scientific Corporation
• 31.3. GE HealthCare Technologies Inc.
• 31.4. Olympus Corporation
• 31.5. Terumo Corporation
• 31.6. Smith and Nephew plc.
• 31.7. Ethicon Inc.
• 31.8. Hologic Inc.
• 31.9. CooperSurgical Inc.
• 31.10. Ferring B.V.
• 31.11. Cook Medical Inc.
• 31.12. Karl Storz GmbH
• 31.13. Merit Medical Systems
• 31.14. CONMED Corporation
• 31.15. Amsino International Inc.

32. Global Uterine Fibroid Embolization Device Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Uterine Fibroid Embolization Device Market

34. Recent Developments In The Uterine Fibroid Embolization Device Market

35. Uterine Fibroid Embolization Device Market High Potential Countries, Segments and Strategies

• 35.1 Uterine Fibroid Embolization Device Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Uterine Fibroid Embolization Device Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Uterine Fibroid Embolization Device Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer

관련자료